IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
IQVIA HOLDINGS INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026
$265.88−1.02 (-0.38%)
Close on Oct 19, 2026
- Market cap
- $45.15B
- P/E (TTM)
- 32.9
- Dividend yield
- –
Iqvia statistics
Financials through Mar 31, 2026, price as of Oct 19, 2026, median of Services-Commercial Physical & Biological Research companies for comparison
Valuation
| Measure | Iqvia | Industry median |
|---|---|---|
| Market Cap | $43.76B | $73.61M |
| Enterprise Value | $57.62B | $55.54M |
| PE Ratio | 32.95 | 25.83 |
| PS Ratio | 2.63 | 3.25 |
| PB Ratio | 7.03 | 3.13 |
| P/FCF Ratio | 20.68 | 20.60 |
| P/OCF Ratio | 16.18 | 15.81 |
Enterprise value
| Measure | Iqvia | Industry median |
|---|---|---|
| EV / Sales | 3.46 | 2.79 |
| EV / EBITDA | 17.11 | 15.81 |
| EV / EBIT | 26.19 | 22.04 |
| EV / FCF | 27.23 | 21.35 |
Income (trailing twelve months)
| Measure | Iqvia | Industry median |
|---|---|---|
| Revenue | $16.63B | $24.74M |
| Gross Profit | $5.49B | $19.54M |
| Operating Income | $2.20B | -$55.64K |
| Pretax Income | $1.60B | $45.62K |
| Net Income | $1.39B | -$97.64K |
| EBITDA | $3.37B | -$29.48K |
| EPS (Diluted) | $8.07 | $0.00 |
Margins
| Measure | Iqvia | Industry median |
|---|---|---|
| Gross Margin | 33.0% | 40.4% |
| Operating Margin | 13.2% | 0.94% |
| Pretax Margin | 9.60% | 2.64% |
| Profit Margin | 8.33% | 0.51% |
| EBITDA Margin | 20.2% | 3.48% |
| FCF Margin | 12.7% | 5.05% |
Returns
| Measure | Iqvia | Industry median |
|---|---|---|
| Return on Equity (ROE) | 22.7% | 0.45% |
| Return on Assets (ROA) | 4.86% | -3.47% |
| Return on Invested Capital (ROIC) | 9.67% | 2.85% |
| Return on Capital Employed (ROCE) | 10.3% | 2.03% |
Growth
| Measure | Iqvia | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 7.32% | 4.26% |
| Net Income Growth (YoY) | 3.82% | -0.74% |
| EPS Growth (YoY) | 9.95% | 9.14% |
| FCF Growth (YoY) | -2.17% | -10.5% |
| Revenue Growth (3Y CAGR) | 4.21% | 2.15% |
| Revenue Growth (5Y CAGR) | 7.50% | 7.37% |
| EPS Growth (3Y CAGR) | 11.1% | 6.08% |
| EPS Growth (5Y CAGR) | 40.5% | 9.81% |
Balance sheet
| Measure | Iqvia | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.10B | $5.43M |
| Total Debt | $15.83B | $85.44M |
| Net Cash (Debt) | -$13.73B | $17.62K |
| Net Cash Per Share | -$83.41 | $0.00 |
| Equity (Book Value) | $6.22B | $10.50M |
| Book Value Per Share | $37.79 | $0.60 |
| Tangible Book Value | -$15.13B | -$78.36K |
| Working Capital | -$2.11B | $2.78M |
Financial position
| Measure | Iqvia | Industry median |
|---|---|---|
| Current Ratio | 0.75 | 1.26 |
| Quick Ratio | 0.65 | 0.65 |
| Debt / Equity | 2.55 | 0.45 |
| Debt / EBITDA | 4.70 | 2.59 |
| Debt / FCF | 7.48 | 3.29 |
| Net Debt / EBITDA | 4.08 | 1.99 |
| Interest Coverage | 2.91 | -0.23 |
Cash flow (trailing twelve months)
| Measure | Iqvia | Industry median |
|---|---|---|
| Operating Cash Flow | $2.70B | $8.04K |
| Capital Expenditures | -$588.00M | -$8.33M |
| Free Cash Flow | $2.12B | $11.03M |
| FCF Per Share | $12.86 | $0.76 |
Efficiency
| Measure | Iqvia | Industry median |
|---|---|---|
| Asset Turnover | 0.58 | 0.83 |
| Revenue Per Employee | $178.84K | $216.23K |
| Profits Per Employee | $14.89K | -$1.99K |
| Employee Count | 93,000 | 115 |
Dividends and yields
| Measure | Iqvia | Industry median |
|---|---|---|
| Earnings Yield | 3.16% | -1.29% |
| FCF Yield | 4.84% | 3.90% |
| Buyback Yield | 3.25% | 1.36% |
| Shareholder Yield | 3.25% | 1.65% |
Shares
| Measure | Iqvia | Industry median |
|---|---|---|
| Shares Outstanding | 164,600,000 | 29,217,800 |
| Shares Change (YoY) | -5.53% | 0.84% |
| Shares Change (QoQ) | -1.59% | 0.00% |
| Float | 162,822,000 | 26,226,050 |
| Shares Held by Insiders | 1.08% | 4.85% |
| Shares Held by Institutions | 95.3% | 83.3% |
Taxes
| Measure | Iqvia | Industry median |
|---|---|---|
| Income Tax | $250.00M | $1.36M |
| Effective Tax Rate | 15.7% | 23.6% |
Scores
| Measure | Iqvia | Industry median |
|---|---|---|
| Graham Number | $82.84 | $16.51 |
| Graham Upside | -68.8% | -50.2% |
| Altman Z-Score | 2.21 | 2.64 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -2.59 | -2.75 |
Calculated by StockData from Iqvia's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.